LianBio (LIANY)
↓ Download CSVKey ratios (FY2022)
-37.6%
Return on equity
| Metric (FY) | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Operating Income | -$125.35M | -$195.57M | -$134.87M | — |
| Net Income | -$110.29M | -$196.30M | -$139.60M | — |
| EPS (Diluted) | $-1.02 | $-5.71 | $-11.58 | — |
| Total Assets | $319.96M | $426.34M | $279.29M | — |
| Total Liabilities | $26.31M | $39.01M | $27.57M | — |
| Shareholders' Equity | $293.65M | $387.34M | -$98.07M | -$14.82M |
| Cash & Equivalents | $79.22M | $228.18M | $254.35M | — |
| Operating Cash Flow | -$99.19M | -$163.95M | -$98.14M | — |
| Capital Expenditures | $1.84M | $947.0K | $886.0K | — |
| Shares Outstanding | 107.04M | 107.28M | 20.48M | — |